FutureTech Medical, LLC – Trademark Portfolio

Entity Type: 16

FutureTech Medical, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VIKON and QUICKRELEASE. The owner is based in Birmingham, AL.

1126 Country Club Circle

Birmingham, AL 35244

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

FutureTech Medical, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does FutureTech Medical, LLC have?

FutureTech Medical, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does FutureTech Medical, LLC file in?

FutureTech Medical, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are FutureTech Medical, LLC's most well-known trademarks?

FutureTech Medical, LLC's registered trademark portfolio includes well-known marks such as VIKON and QUICKRELEASE. These are among 2 currently registered trademarks in the portfolio.

What is FutureTech Medical, LLC's trademark registration success rate?

FutureTech Medical, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.